Chemical Resources   Report issue

For profit Phase 4
Founded: Panchkula India (2003)
Status: No NME R&D (2003)

Organization Overview

First Clinical Trial
2013
NCT02700477
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

fenugreek seed extract (6 trials)

prunus domestica (1 trial)

Drugs in Other Trials (4)

coffee (1 trial)

fenugreek extract (1 trial)

sitagliptin (januvia) (1 trial)

sufonylurea (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Ovarian Cysts (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 6